Nevada Cannabis Board adopts broad regulatory package after heated debate over lab standards and sample sizes

The Nevada Cannabis Compliance Board voted June 18 to adopt a broad set of permanent regulations in LCB file R152-24/RP1 that revise licensing, enforcement, laboratory testing, packaging, labeling and other rules governing the state cannabis industry.

The package, developed from work that began after the 2023 legislative session and revised through LCB review, was approved by voice vote after extended public comment and board discussion over laboratory standards and the proposed increase in usable testing sample size.

Why it matters: The adopted regulations incorporate numerous technical standards and establish procedures affecting cultivators, testing laboratories, sales facilities and consumption lounges. Stakeholders warned the rules could impose significant operational and compliance costs if staff or the Legislative Counsel Bureau interpret incorporation-by-reference of external scientific standards too broadly.

What the board decided: After public testimony and internal discussion, the board voted to adopt R152-24/RP1 as submitted to the Legislative Counsel Bureau. The motion to adopt as filed was seconded and passed by voice vote; the transcript records a voice vote but does not list a roll-call tally.

Stakeholder concerns and exchanges

Laboratories and industry representatives urged narrower, clearer language about how outside technical publications are used. "The listing of publication in this section or any subsequent section does not prohibit the board or appropriate board agent from approving an alternate method," Adam Fulton, representing seven Nevada laboratories, said, urging the board to preserve authority to approve scientifically valid alternatives. Fulton warned the package’s section 62 and section 66 could be read to require wholesale adherence to roughly 36 external standards (which he estimated at about 6,900 pages) and described contradictions among the referenced publications.

CCB staff and legal counsel responded that the intent of section 62 is to incorporate publications "only as required by a specific regulation," and that the agency plans to publish on its website which standards will be applied. "Section 62 intends that publications be complied with only as required by a specific regulation for these different standards," said an agency representative on the record.

Sample-size dispute

A central point of contention was a proposed increase in the minimum usable testing sample from 10 grams to 20 grams for a 5-pound flower lot. Supporters, including CCB laboratory staff, argued a larger sample ensures sufficient material for combined chemical and microbial testing and aligns with industry testing practices. "With each microbial test requiring 1 g of sample, we increased from 10 to 20 g to ensure laboratories have enough sample for all of the chemical and microbial tests combined," Lynette Cogler, laboratory compliance supervisor, said.

Opponents, including trade group and industry counsel, urged caution because related statutory changes (SB 157) contemplate different composite sample and lot-size rules. "If the board approves this increase to 20 g but doesn't correspondingly increase the 15-lb lot size, we're asking licensees to change testing procedures now while knowing pending regulations may require further change," Lake Martin, Executive Director of the Nevada Cannabis Association, said.

Several board members proposed compromise alternatives (including a 15‑gram minimum) but legal staff cautioned that changing the numeric standard at this late procedural stage might be treated as a substantive amendment by the Legislative Counsel Bureau and delay the package’s approval. To avoid stalling the entire regulatory package, the board ultimately adopted the package as filed.

Legal and procedural context

Emily Bordelon, senior deputy attorney general and lead counsel for the board, outlined the administrative history: the package began in 2023, was submitted to LCB in 2024, revised in 2025 and returned to the board as R152-24RP1. Bordelon and LCB staff said chapter 11 (laboratory testing) was heavily scrutinized after stakeholder concerns and was included in the consolidated file because LCB required the package be considered as a single regulatory submission.

Other technical points and clarifications

- The package authorizes the board to issue notices of violation, administrative fines, subpoenas and civil actions to enjoin unlicensed activity and recover penalties (staff noted civil penalties of up to $50,000 are authorized in the text presented). - Sections address requirements for soil amendment reporting, certificate of analysis timelines (three business days after receipt by a lab), chain-of-custody, quality assurance and written ethics policies for independent testing laboratories, and requirements for signage, packaging and consumer disclosures at sales facilities and consumption lounges. - Industry speakers asked the board to clarify drafting errors that unintentionally restricted branded merchandise (for example, prohibiting certain imagery such as fruit on allowed accessories); staff indicated the issue was inadvertent and would be fixed in a forthcoming package.

Next steps and implementation

Staff said the agency will publish a list of the specific external standards to be applied and will offer routine compliance assistance to licensees. The board also announced a conversion of the Nevada Cannabis Compliance Regulations (NCCRs) into Nevada Administrative Code (NAC) entries (NAC 678A–D) with an anticipated transition date of August 1, 2026, and a resource fair planned for June 24, 2026, to help licensees adjust to the new rules.

The meeting also included a brief federal update: staff noted the Department of Justice’s April 2026 order that placed FDA-approved medical marijuana and state-licensed medical marijuana into Schedule III is under challenge in the D.C. Circuit, and the Drug Enforcement Administration plans an expedited administrative hearing beginning June 29, 2026, to consider broader rescheduling issues. Staff advised licensees to consult counsel before making business decisions based on federal actions.

What was not resolved

Industry and laboratory representatives requested clearer statutory cross-references and a mechanism that explicitly allows the board or its agents to approve alternate scientifically valid laboratory methods when appropriate; the board directed staff to continue working with stakeholders on implementation and guidance.

The board adjourned on June 18, 2026. The regulations adopted on June 18 will proceed through the LCB/Legislative Commission process as required by the administrative procedure rules.